Sustainable Mission Focus European Vaccine Initiative (EVI) is dedicated to developing safe, effective, and affordable vaccines for diseases of poverty, positioning it as a key partner for organizations seeking to fund or collaborate on global health initiatives with a focus on social impact.

Strategic Partnerships EVI has established collaborations with leading pharmaceutical and research organizations such as Hilleman Laboratories and Merck Millipore, opening opportunities for suppliers of biotech, formulation, and research services to engage with a well-connected, mission-driven organization.

Research & Development Catalyst With its active role in coordinating EU-funded consortia and accelerating vaccine development, EVI offers potential avenues for technology providers, research equipment suppliers, and innovative biotech firms aiming to support vaccine R&D efforts.

Tech Stack Modernization Utilizing modern web technologies like React, Drupal, and Wix, EVI demonstrates an openness to digital engagement, providing opportunities for digital marketing, platform development, and cloud-based solutions to help streamline its global collaboration efforts.